1. Home/
  2. Compounds/
  3. Bicalutamide



SourcesNames Used
GDSC1000, FIMMBicalutamide
PharmacoGx Bicalutamide

External IDs

Smiles: CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
Pubchem: 2375

Annotated Targets


Cell lines tested with Bicalutamide

1043 cell lines have been tested with this compound, using data from 2 dataset(s).
DU-4475 breast GDSC1000, FIMM3
OCI-AML5 haematopoietic and lymphoid tissue GDSC1000, FIMM3
HCC1143 breast GDSC1000, FIMM3
HCC1937 breast GDSC1000, FIMM3
MDA-MB-453 breast GDSC1000, FIMM3
PC-3 prostate GDSC1000, FIMM3
KGN ovary GDSC1000, FIMM3
CAL-51 breast GDSC1000, FIMM3
CCRF-CEM haematopoietic and lymphoid tissue GDSC1000, FIMM3
MV-4-11 haematopoietic and lymphoid tissue GDSC1000, FIMM3
Download CSV
Download Data as CSV

Top molecular features associated with response to Bicalutamide

Feature TypeStandardized
Nominal ANOVA
mRNA TGFBR2 GDSC1000 AAC 0.18 4e-07
mRNA DKK1 GDSC1000 AAC 0.18 3e-06
mRNA FEZF2 GDSC1000 AAC 0.15 5e-06
mRNA ECM2 GDSC1000 AAC 0.15 2e-05
mRNA PLAU GDSC1000 AAC 0.17 3e-05
mRNA TRIM24 GDSC1000 AAC -0.14 4e-05
mRNA FOSL1 GDSC1000 AAC 0.15 4e-05
mRNA TNKS FIMM AAC 0.63 4e-05
mRNA UNC80 GDSC1000 AAC -0.14 5e-05
mRNA HRH1 GDSC1000 AAC 0.15 5e-05
Download CSV